Therapy News and Research

RSS

New study emphasizes the importance of metabolomics to the advent of personalized medicine

International experts have collaborated on a comprehensive collection of reviews focusing on the emerging interface between metabolomics and pharmacogenomics.

24 Oct 2006

Combination therapy of salmeterol and fluticasone improves survival in patients with COPD

A combination of two common medications may help patients with chronic obstructive pulmonary disease (COPD) live longer.

23 Oct 2006

Statins show promise in slowing smoking-induced lung damage

In a new study presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians (ACCP), current and former smokers who used statins had lower lung function decline than those not using statins, regardless of whether patients continued or stopped smoking.

23 Oct 2006

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

A multifaceted intervention designed to increase adherence with clinical guidelines for preventing deep-vein blood clots may decrease the rate of such blood clots among elderly patients, according to a report in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

Further European investment in genomics

The Economic and Social Research Council (ESRC) has announced continued funding, from 2007 to 2012, for its three research centres, CESAGen, EGENIS and INNOGEN, that, along with the ESRC Genomics Policy and Research Forum, make up the ESRC Genomics Network.

23 Oct 2006

New smart anti-microbial approach to preventing tooth decay

Preventing cavities could one day involve the dental equivalent of a military surgical strike. A team of researchers supported by the National Institute of Dental and Craniofacial Research report they have created a new smart anti-microbial treatment that can be chemically programmed in the laboratory to seek out and kill a specific cavity-causing species of bacteria, leaving the good bacteria untouched.

23 Oct 2006

Identifying breast cancer patients most likely to benefit from Aromatase Inhibitor Therapy after adjuvant radiation and Tamoxifen

While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual.

23 Oct 2006

New biologic treatment for tennis elbow

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine.

23 Oct 2006

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

The Wall Street Journal on Saturday examined the debate over the risks and efficacy of alternatives to hormone replacement therapy for treatment of menopausal symptoms.

23 Oct 2006

Functionalization of individual ultra-short single-walled carbon nanotubes

While most research aimed at developing carbon nanotubes as tumor-targeting drug and imaging agent delivery vehicles has focused on full-length nanotubes, Lon Wilson, Ph.D., and his colleagues at Rice University have been working with ultra-short nanotubes that cells appear to take up more efficiently than their longer counterparts.

23 Oct 2006

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Targeted tumor therapy lobs toxic payloads directly into tumors to destroy cancer cells while leaving normal cells unharmed.

20 Oct 2006

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging.

20 Oct 2006

PGC-1 alpha implicated in Huntington's disease neurodegeneration

A metabolic disorder underlies the brain effects found in those with Huntington's disease, researchers report in an advance article publishing online October 19, 2006. The article will appear in the November 2006 issue of the journal Cell Metabolism, published by Cell Press.

20 Oct 2006

UT Southwestern looks at promising new medication that reduces the severity and frequency of asthma attacks

UT Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.

20 Oct 2006

Researchers discover new method of mapping how bacteria spread within the body

Researchers at the University of Cambridge have discovered a new, more accurate, method of mapping how bacteria spread within the body, a breakthrough that could lead to more effective treatments and prevention of certain bacterial infections.

20 Oct 2006

FDA advisory panel recommends adding warning label to Tamoxifen

An FDA advisory panel on Wednesday recommended that a warning label be added to tamoxifen, an agency-approved drug for treating and preventing breast cancer, the AP/Seattle Post-Intelligencer reports (Bridges, AP/Seattle Post-Intelligencer, 10/18).

19 Oct 2006

NC State researchers receive $3.5 million to tackle HIV

Researchers at North Carolina State University have received a $3.5 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop mathematical and statistical models that will aid in designing new treatment strategies for HIV patients.

19 Oct 2006

New treatment option gives hope to victims of head and neck cancers

More than 640,000 people worldwide are diagnosed with head and neck cancer each year, and more than 350,000 die from the disease annually.

19 Oct 2006

Psychiatrist in the UK up on 10 charges regarding sex change patients

A psychiatrist in Britain well known for dealing with issues of gender has been brought before the General Medical Council (GMC) on 10 charges of serious professional misconduct with regard to his treatment of patients.

19 Oct 2006

FDA approves Taxotere for head and neck cancers

The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).

18 Oct 2006

Therapy News and Research

New study emphasizes the importance of metabolomics to the advent of personalized medicine

Combination therapy of salmeterol and fluticasone improves survival in patients with COPD

Statins show promise in slowing smoking-induced lung damage

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

Further European investment in genomics

New smart anti-microbial approach to preventing tooth decay

Identifying breast cancer patients most likely to benefit from Aromatase Inhibitor Therapy after adjuvant radiation and Tamoxifen

New biologic treatment for tennis elbow

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

Functionalization of individual ultra-short single-walled carbon nanotubes

Targeted tumor therapy has paramount consequences for future expansion of nuclear medicine

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

PGC-1 alpha implicated in Huntington's disease neurodegeneration

UT Southwestern looks at promising new medication that reduces the severity and frequency of asthma attacks

Researchers discover new method of mapping how bacteria spread within the body

FDA advisory panel recommends adding warning label to Tamoxifen

NC State researchers receive $3.5 million to tackle HIV

New treatment option gives hope to victims of head and neck cancers

Psychiatrist in the UK up on 10 charges regarding sex change patients

FDA approves Taxotere for head and neck cancers

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News